相关实验视频

Updated: May 12, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

小细胞肺癌中的分子亚型和向治疗策略:进展,挑战和未来前景

Daoyuan Huang¹, Jingchao Wang¹, Li Chen¹

¹Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Molecules (Basel, Switzerland)

|May 7, 2025

概括

小细胞肺癌 (SCLC) 是一种具有明显分子亚型的致命癌症. 了解这些亚型是开发向治疗和改善患者存活率的关键.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因组学就是基因组学.

背景情况:

小细胞肺癌 (SCLC) 是一种具有高转移率和复发率的侵袭性恶性瘤.
历史上被视为一个单一的实体,SCLC现在被认为包括不同的分子亚型.
这些亚型是由决定血统的转录因子 (ASCL1,NEUROD1,POU2F3,YAP1) 和炎症亚型 (SCLC-I) 定义的.

研究的目的:

突出与不同SCLC分子亚型相关的治疗脆弱性.
强调了解SCLC异质性,可塑性和抵抗机制的重要性.
讨论新兴的治疗策略和精密医学在SCLC治疗中的作用.

主要方法:

多原子研究以识别和分类SCLC分子亚型.
对特定亚型的治疗脆弱性和抵抗机制的分析.
对新型治疗药物的审查,包括BCL2抑制剂,DLL3向药物和免疫检查点抑制剂 (ICI).

主要成果:

SCLC分子亚型表现出独特的脆弱性,为向治疗提供了机会.
瘤异质性,可塑性和耐治疗性仍然是SCLC治疗中的重大挑战.
免疫检查点抑制剂 (ICI) 在特定的SCLC亚型中表现有前途.

结论:

更深入地了解SCLC亚型特征和调节机制对于优化精密治疗至关重要.
识别特定亚型的标和克服耐药性对于开发个性化组合治疗至关重要.
整合多原子数据和分子监测将推进SCLC亚型特定疗法,并改善患者的治疗结果.

关键词:

在ASCL1中,尼乌罗德1是什么意思在POU2F3F3中.在SCLC中,SCLC是最重要的.一个YAP1一个YAP1 免疫检查点是一个检查点.有针对性的治疗方法.这是一种治疗疗法.瘤发生的起源

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...